Key points are not available for this paper at this time.
The synthesis of nanoscaled β-Bi(2)O(3) starting from the bismuth oxido clusters Bi(6)O(4)(OH)(4)(NO(3))(6)·H(2)O, Bi(22)O(26)(OSiMe(2)(t)Bu)(14), Bi(38)O(45)(NO(3))(20)(DMSO)(28)(NO(3))(4)·4DMSO and Bi(38)O(45)(OMc)(24)(DMSO)(9)·2DMSO·7H(2)O (OMc = O(2)CC(3)H(5)) under ambient conditions is reported. The metal oxido clusters are regarded as ideal precursors for β-Bi(2)O(3) due to their structural relationship with the latter. Nevertheless, different bismuth oxide polymorphs are accessible dependent on the hydrolysis protocol. Hydrolysis over a period of 18 h gave stable α-Bi(2)O(3) whereas after 3 min an amorphous material is observed. Annealing of the amorphous material at 370 °C gave nanoscaled β-Bi(2)O(3). An unusual high reactivity of the β-Bi(2)O(3) particles with SiO(2) and Al(2)O(3) is observed at temperatures above 400 °C. Powder X-ray diffraction studies, transmission electron microscopy, diffuse reflectance UV/Vis spectroscopy and nitrogen adsorption measurements are used for characterization of the as-prepared β-Bi(2)O(3) nanoparticles. The properties of the β-Bi(2)O(3) nanoparticles depend on the starting bismuth oxido clusters with regard to particle size and optical band gap. The β-Bi(2)O(3) nanoparticles show excellent photocatalytic activity as demonstrated by dye decomposition (rhodamine B, methyl orange, methylene blue and orange G) under visible light.
Schlesinger et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: